Johnson & Johnson Earnings Are Imminent; These Most Accurate …

Jan 22, 2025 · Johnson & Johnson JNJ will release earnings results for its fourth quarter, before the opening bell on Wednesday, Jan. 22, 2025. Analysts expect the New Brunswick, New Jersey-based company to ...

CouponFollow Extension

01%
OFF

Johnson & Johnson (JNJ) Tops Q3 Earnings And Revenue Estimates

2 weeks from now

Oct 15, 2024 · Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 9.01% and 1.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to …

yahoo.com

$2.57
OFF

Earnings Preview: Johnson & Johnson (JNJ) Q3 Earnings Expected …

2 weeks from now

Oct 11, 2022 · For the last reported quarter, it was expected that Johnson & Johnson would post earnings of $2.57 per share when it actually produced earnings of $2.59, delivering a surprise …

nasdaq.com

$4
OFF

Johnson & Johnson (JNJ) Is On Track For A Record-Setting 2024

2 weeks from now

Aug 18, 2024 · Therefore, net income for the quarter was $4.7 billion, with earnings per share (EPS) at $1.93, down from $2.05 in the same period last year. However, when adjusted for …

nasdaq.com

01%
OFF

Will Johnson & Johnson (JNJ) Beat Estimates Again In Its Next …

2 weeks from now

Jan 1, 2025 · For the most recent quarter, Johnson & Johnson was expected to post earnings of $2.22 per share, but it reported $2.42 per share instead, representing a surprise of 9.01%.

nasdaq.com

FAQs about Johnson & Johnson Earnings Are Imminent; These Most Accurate … Coupon?

How much did Johnson & Johnson (JNJ) earn?

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.66 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 9.01%. ...

Did Johnson & Johnson beat earnings expectations in Q4?

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast. J&J said fourth-quarter earnings slipped 26% to $3.52 billion and revenue declined 4.4% to $23.71 billion. ...

Is Johnson & Johnson (J&J) a good stock to buy?

For Johnson & Johnson, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -3.20%. On the other hand, the stock currently carries a Zacks Rank of #4. ...

How can investors track Johnson & Johnson earnings estimate revisions?

Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Johnson & Johnson: mixed. ...

What happened to Johnson & Johnson shares?

After a brief surge following the company's third-quarter earnings report, Johnson & Johnson shares trended lower from mid-October through the end of 2024, ending the year down nearly 8%. They've gained close to 2% in January so far, at $147.03 as of Friday's close. ...

Will Johnson & Johnson stock rise in 2024?

The company's stock trended lower in the final months of 2024, but analysts anticipate it could rise in the coming months. Johnson & Johnson faces several challenges entering the new year, including risks to its credit rating and unresolved class action lawsuits. ...